PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6(high) uterine leiomyosarcoma to PD-1 blockade.

De Wispelaere W, Annibali D, Tuyaerts S, Messiaen J, Antoranz A, Shankar G, Dubroja N, Herreros-Pomares A, Baiden-Amissah REM, Orban MP, Delfini M, Berardi E, Van Brussel T, Schepers R, Philips G, Boeckx B, Baietti MF, Congedo L, HoWangYin KY, Bayon E, Van Rompuy AS, Leucci E, Tabruyn SP, Bosisio F, Mazzone M, Lambrechts D, Amant F

Open source

DOI
10.1002/ctm2.1655
Published
2024 May
Container
Clinical and translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.1655,
  title = {PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6(high) uterine leiomyosarcoma to PD-1 blockade.},
  author = {De Wispelaere W and Annibali D and Tuyaerts S and Messiaen J and Antoranz A and Shankar G and Dubroja N and Herreros-Pomares A and Baiden-Amissah REM and Orban MP and Delfini M and Berardi E and Van Brussel T and Schepers R and Philips G and Boeckx B and Baietti MF and Congedo L and HoWangYin KY and Bayon E and Van Rompuy AS and Leucci E and Tabruyn SP and Bosisio F and Mazzone M and Lambrechts D and Amant F},
  year = {2024},
  journal = {Clinical and translational medicine},
  doi = {10.1002/ctm2.1655},
  url = {https://doi.org/10.1002/ctm2.1655}
}

RIS

TY  - JOUR
TI  - PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6(high) uterine leiomyosarcoma to PD-1 blockade.
AU  - De Wispelaere W
AU  - Annibali D
AU  - Tuyaerts S
AU  - Messiaen J
AU  - Antoranz A
AU  - Shankar G
AU  - Dubroja N
AU  - Herreros-Pomares A
AU  - Baiden-Amissah REM
AU  - Orban MP
AU  - Delfini M
AU  - Berardi E
AU  - Van Brussel T
AU  - Schepers R
AU  - Philips G
AU  - Boeckx B
AU  - Baietti MF
AU  - Congedo L
AU  - HoWangYin KY
AU  - Bayon E
AU  - Van Rompuy AS
AU  - Leucci E
AU  - Tabruyn SP
AU  - Bosisio F
AU  - Mazzone M
AU  - Lambrechts D
AU  - Amant F
PY  - 2024
JO  - Clinical and translational medicine
DO  - 10.1002/ctm2.1655
UR  - https://doi.org/10.1002/ctm2.1655
ER  - 

APA

W, D. W., D, A., S, T., J, M., A, A., G, S., N, D., A, H., REM, B., MP, O., M, D., E, B., T, V. B., R, S., G, P., B, B., MF, B., L, C., KY, H., E, B., AS, V. R., E, L., SP, T., F, B., M, M., D, L., & F, A. (2024). PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6(high) uterine leiomyosarcoma to PD-1 blockade.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.1655

Source records